{"id":1130975,"title":"DSEN Abstract: Assessing the potential for additive toxicity arising from the combined use of immune checkpoint inhibitors and of tyrosine kinase inhibitors - CIHR","sourceCode":"cihr","sourceName":"Canadian Institutes of Health Research","language":"en","captureDate":"2026-04-18","captureTimestamp":"2026-04-18T16:29:32.383000+00:00","jobId":8,"originalUrl":"https://cihr-irsc.gc.ca/e/54101.html","snippet":"DSEN Abstract Assessing the potential for additive toxicity arising from the combined use of immune checkpoint inhibitors and of tyrosine kinase inhibitors Summary This rapid systematic review examined the potential additive toxicity associated with combined use of immune check…","rawSnapshotUrl":"/api/snapshots/raw/1130975","browseUrl":"https://replay.healtharchive.ca/job-8/20260418162932/https://cihr-irsc.gc.ca/e/54101.html#ha_snapshot=1130975","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}